Trial Profile
A retrospective trial to evaluate the efficacy and safety of Sipuleucel-T in patients with metastatic castration-resistant prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2016
Price :
$35
*
At a glance
- Drugs Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Apr 2016 New trial record